177 related articles for article (PubMed ID: 29529997)
1. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.
Liang W; Song L; Peng Z; Zou Y; Dai S
BMC Cancer; 2018 Mar; 18(1):279. PubMed ID: 29529997
[TBL] [Abstract][Full Text] [Related]
2. Association between male pattern baldness and testicular germ cell tumor: a meta-analysis.
Zhou J; Xia S; Li T; Liu R
BMC Cancer; 2019 Jan; 19(1):53. PubMed ID: 30634927
[TBL] [Abstract][Full Text] [Related]
3. Association between male pattern baldness and prostate disease: A meta-analysis.
Jin T; Wu T; Luo Z; Duan X; Deng S; Tang Y
Urol Oncol; 2018 Feb; 36(2):80.e7-80.e15. PubMed ID: 29054497
[TBL] [Abstract][Full Text] [Related]
4. Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis.
Amoretti A; Laydner H; Bergfeld W
J Am Acad Dermatol; 2013 Jun; 68(6):937-43. PubMed ID: 23395589
[TBL] [Abstract][Full Text] [Related]
5. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
6. Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.
He H; Xie B; Xie L
Medicine (Baltimore); 2018 Jul; 97(28):e11379. PubMed ID: 29995779
[TBL] [Abstract][Full Text] [Related]
7. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
Lis-Święty A; Arasiewicz H; Ranosz-Janicka I; Brzezińska-Wcisło L
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1815-1818. PubMed ID: 29237093
[TBL] [Abstract][Full Text] [Related]
8. Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults: a meta-analysis and systematic review.
Tan IB; Ang KK; Ching BC; Mohan C; Toh CK; Tan MH
Cancer; 2010 Oct; 116(19):4520-32. PubMed ID: 20578177
[TBL] [Abstract][Full Text] [Related]
9. Baldness and testicular cancer: the EPSAM case-control study.
Moirano G; Zugna D; Grasso C; Lista P; Ciuffreda L; Segnan N; Merletti F; Richiardi L
Andrology; 2016 Mar; 4(2):251-6. PubMed ID: 26941123
[TBL] [Abstract][Full Text] [Related]
10. Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis.
Gandaglia G; Becker A; Trinh QD; Abdollah F; Schiffmann J; Roghmann F; Tian Z; Montorsi F; Briganti A; Karakiewicz PI; Sun M
Eur J Surg Oncol; 2014 Jan; 40(1):103-12. PubMed ID: 24099755
[TBL] [Abstract][Full Text] [Related]
12. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
13. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
[TBL] [Abstract][Full Text] [Related]
14. Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.
Zhou CK; Littman AJ; Levine PH; Hoffman HJ; Cleary SD; White E; Cook MB
Prostate; 2015 Mar; 75(4):415-23. PubMed ID: 25492530
[TBL] [Abstract][Full Text] [Related]
15. Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.
Khan S; Caldwell J; Wilson KM; Gonzalez-Feliciano AG; Peisch S; Pernar CH; Graff RE; Giovannucci EL; Mucci LA; Gerke TA; Markt SC
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1229-1236. PubMed ID: 32277004
[TBL] [Abstract][Full Text] [Related]
16. Male pattern baldness and the risk of prostate cancer.
Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
[TBL] [Abstract][Full Text] [Related]
18. Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.
Cremers RG; Aben KK; Vermeulen SH; den Heijer M; van Oort IM; Kiemeney LA
Eur J Cancer; 2010 Dec; 46(18):3294-9. PubMed ID: 20561779
[TBL] [Abstract][Full Text] [Related]
19. Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer.
van Walraven C; Fergusson D; Earle C; Baxter N; Alibhai S; MacDonald B; Forster AJ; Cagiannos I
J Clin Oncol; 2011 Jul; 29(21):2883-8. PubMed ID: 21690479
[TBL] [Abstract][Full Text] [Related]
20. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007).
Andreassen KE; Grotmol T; Cvancarova MS; Johannesen TB; Fosså SD
Int J Cancer; 2011 Dec; 129(12):2867-74. PubMed ID: 21626506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
